The fate of bezafibrate, carbamazepine, ciprofloxacin and clarithromycin in the wastewater treatment process
Conference paper
Revitt, D., Tuckwell, R., Garelick, H., Jones, H. and Lundy, L. 2017. The fate of bezafibrate, carbamazepine, ciprofloxacin and clarithromycin in the wastewater treatment process. 14th IWA/IAHR International Conference on Urban Drainage. Prague, Czech Republic 10 - 15 Sep 2017 pp. 493-500
Type | Conference paper |
---|---|
Title | The fate of bezafibrate, carbamazepine, ciprofloxacin and clarithromycin in the wastewater treatment process |
Authors | Revitt, D., Tuckwell, R., Garelick, H., Jones, H. and Lundy, L. |
Abstract | The progress of four pharmaceuticals (bezafibrate, carbamazepine, clarithromycin and ciprofloxacin) is followed through the treatment stages (screened sewage, settled sewage and final effluent) of a large urban wastewater treatment plant (WWTP) employing activated sludge treatment. Concentrations at the inlet to the WWTP are generally higher than those predicted from consideration of local pharmaceutical consumption and typical excretion data. Percentage removal efficiencies are variable (22.5 – 94.3%) with carbamazepine being the most resistant to elimination. |
Conference | 14th IWA/IAHR International Conference on Urban Drainage |
Page range | 493-500 |
Publication dates | |
10 Sep 2017 | |
Publication process dates | |
Deposited | 11 Oct 2017 |
Accepted | 09 May 2017 |
Output status | Published |
Accepted author manuscript | |
Language | English |
Book title | Proceedings of the 14th IWA/IAHR International Conference on Urban Drainage |
Permalink -
https://repository.mdx.ac.uk/item/8734w
Download files
70
total views10
total downloads1
views this month0
downloads this month